AnaptysBio (ANAB)
(Delayed Data from NSDQ)
$25.01 USD
-0.06 (-0.24%)
Updated May 20, 2024 04:00 PM ET
After-Market: $24.99 -0.02 (-0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -1.34 |
EPS Last Quarter | -1.64 |
Last EPS Surprise | -6.49% |
ABR | 1.55 |
Earnings ESP
|
1.37% |
---|---|
Current Year | -6.14 |
Next Year | -6.38 |
EPS (TTM) | -6.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.75M | 7.03M | 22.28M | 32.06M |
# of Estimates | 3 | 4 | 5 | 4 |
High Estimate | 9.00M | 10.00M | 37.00M | 54.00M |
Low Estimate | 6.70M | 3.00M | 7.18M | 12.00M |
Year ago Sales | 3.46M | 3.32M | 17.16M | 22.28M |
Year over Year Growth Est. | 123.87% | 111.66% | 29.85% | 43.88% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.34 | -1.63 | -6.14 | -6.38 |
# of Estimates | 6 | 6 | 6 | 6 |
Most Recent Consensus | -1.53 | -1.58 | -6.30 | -6.61 |
High Estimate | -0.02 | -1.41 | -5.30 | -4.73 |
Low Estimate | -1.73 | -1.79 | -6.83 | -7.50 |
Year ago EPS | -1.50 | -1.41 | -6.08 | -6.14 |
Year over Year Growth Est. | 10.67% | -15.60% | -0.99% | -3.85% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 2 | 0 |
Up Last 30 Days | 1 | 0 | 2 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 1 | 0 | 1 |
Down Last 30 Days | 3 | 5 | 3 | 5 |
Down Last 60 Days | 2 | 3 | 3 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.34 | -1.63 | -6.14 | -6.38 |
7 Days Ago | -1.64 | -1.61 | -6.50 | -6.33 |
30 Days Ago | -1.53 | -1.50 | -6.13 | -5.94 |
60 Days Ago | -1.44 | -1.51 | -5.92 | -5.69 |
90 Days Ago | -1.62 | -1.57 | -6.47 | -6.48 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.32 | -1.67 | -6.23 | -6.15 |
Zacks Consensus Estimate | -1.34 | -1.63 | -6.14 | -6.38 |
Earnings ESP | 1.37% | -2.66% | -1.50% | 3.52% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.64 | -1.59 | -1.41 | -1.50 | NA |
Estimate | -1.54 | -1.74 | -1.72 | -1.65 | NA |
Difference | -0.10 | 0.15 | 0.31 | 0.15 | 0.13 |
Surprise | -6.49% | 8.62% | 18.02% | 9.09% | 7.31% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more